Evidence map›Paper›PMID 41976130›Full record

ArticleMolecules (Basel, Switzerland)2026

Study on the Browning Mechanism of Multivitamin Iron Oral Solution Based on Sucrose-Lysine Maillard Reaction.

Caifeng Su, Jianping Zhu, Zhuangwei Liu, Juying Tan, Jie Jiang, Zhuang Zhao

Abstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Caifeng SuSchool of Pharmacy, Guangxi Medical University, Nanning 530021, China.
Jianping ZhuGuangxi Institute for Drug Control, Nanning 530021, China.ORCID 0009-0001-0838-223X
Zhuangwei LiuGuangxi Institute for Drug Control, Nanning 530021, China.
Juying TanGuangxi Institute for Drug Control, Nanning 530021, China.
Jie JiangGuangxi Institute for Drug Control, Nanning 530021, China.
Zhuang ZhaoGuangxi Institute for Drug Control, Nanning 530021, China.ORCID 0009-0006-3923-5386

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Severe browning often occurs in Multivitamin Iron Oral Solution during storage, which directly leads to the decline of product quality. To clarify the main mechanism of browning in this preparation, the contents of 5-hydroxymethylfurfural (5-HMF) and carbohydrates, as well as the relevant characteristic parameters such as color and fluorescence, were determined at different storage times in this study. Subsequently, four reaction models, namely sucrose-lysine, sucrose-citric acid, sucrose-niacin, and sucrose-folic acid, were constructed according to the formulation of the preparation to systematically investigate the effects of each system on browning. The results showed that the sucrose-lysine model was the main color-forming reaction system of the preparation. Citric acid could significantly promote the hydrolysis of sucrose to produce two reducing sugars, glucose and fructose, which not only provided sufficient substrates for the Maillard reaction (MR), but also led to the massive accumulation of 5-HMF. Further analysis revealed that heating temperature and heating time were significantly positively correlated with the contents of 5-HMF, browning index (BI), color density (CD), and reducing sugars in the solution, while significantly negatively correlated with sucrose content (

Indexed as

IronLysineMaillard ReactionSucroseVitaminsAdministration, OralFuraldehydeSolutions5-hydroxymethylfurfuralFuraldehydeIronLysineSolutionsSucroseVitamins5-Hydroxymethylfurfuralbrowning mechanismcitric acidMaillard reactionMultivitamin Iron Oral Solutionsucrose-lysineUPLC-Q-TOF-MS/MS

Identifiers

PMID41976130
PMCPMC13074459

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.